Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Oncology News

ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice.

Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.

1548 results

06 Mar 2019

Cytotoxic Therapy; Bioethical Principles and GCP

Biosimilars have a fascinating story of development and understanding it is crucial for widespread adoption

Biosimilars have a fascinating story of development, says Rosa Giuliani, and understanding it is crucial for widespread adoption.

06 Mar 2019

Cytotoxic Therapy; Breast Cancer; Thoracic Malignancies

EMA Recommends Approval of Pazenir for the Treatment of Metastatic Breast Cancer and NSCLC

Pazenir is a generic of Abraxane which has been authorised in the EU since 2008

05 Mar 2019

Targeted Therapy; Cytotoxic Therapy; Thoracic Malignancies

EMA Recommends Granting a Conditional Marketing Authorisation for Lorlatinib

It is intended for treatment of patients with ALK-positive advanced NSCLC previously treated with other ALK tyrosine kinase inhibitors

04 Mar 2019

Targeted Therapy; Cytotoxic Therapy; Breast Cancer

EMA Recommends an Extension of Indications for Olaparib

New indication concerns treatment of adult patients with germline BRCA1/2-mutations, who have HER2-negative locally advanced or metastatic breast cancer

01 Mar 2019

Cytotoxic Therapy; Breast Cancer